A new rapid test for the early diagnosis of preeclampsia, a potentially life-threatening complication of pregnancy, has been developed by a team of researchers at the University of Technology Sydney (UTS). The test is significantly faster and more accurate than current methods.
Currently, the diagnosis of preeclampsia involves measuring blood pressure and testing for protein in the urine, along with other clinical signs and symptoms. Adding to the complexity is the fact that preeclampsia is a multifactorial disease with varying symptoms and features, so the diagnosis can be missed or delayed, particularly for those living in rural and remote areas.
The new strip-based lateral flow assay uses innovative nanoparticle-based technology to detect the concentration of specific biomarkers present in the blood plasma of women with preeclampsia. The novel protein biomarkers, called FKBPL and CD44, were discovered by Associate Professor Lana McClements.
The development of the nanophotonic platform used in the rapid test was led by Distinguished Professor Dayong Jin, director of the UTS Institute for Biomedical Materials and Devices.
Associate Professor McClements said the new test can produce results within 15 minutes and is highly sensitive and specific. “We believe this test has the potential to revolutionize the way preeclampsia is diagnosed and managed,” she said.
The research team conducted a study using clinical samples in collaboration with the Mercy Hospital for Women in Melbourne to validate the effectiveness of the test. They found that the test showed significantly improved sensitivity (90.5% vs. 73.7%) and specificity (100% vs. 92.3%) compared to the most up-to-date method currently available.
The study, “Quantitative Point of Care Tests for Timely Diagnosis of Early-onset Preeclampsia with High Sensitivity and Specificity,” has just been published in Angewandte Chemie International Edition. First authors, UTS Ph.D. candidate Sahar Ghorbanpour and Dr. Shihui Wen, performed the experiments and developed the prototype.
The new test can be performed at the point-of-care, such as a pre-natal clinic or doctor’s office. “This essentially gives clinicians the ability to make immediate and life-saving informed decisions, and not wait 24 hours for the results to come back,” Associate Professor McClements said.
At present, the only known cure for preeclampsia is delivery of the baby, however premature delivery can lead to complications and hospitalization.
“In addition to the new test, the novel biomarkers also show potential as drug and cell therapy targets of emerging treatments for preeclampsia. This offers hope not only for earlier diagnosis, but also for a future cure to this terrible disorder,” Associate Professor McClements said.
The research team is now working to commercialize the test in collaboration with industry partners and hopes to eventually make it widely available to healthcare providers around the world.
“This is a major advance over current methods of diagnosis, which can be unreliable and time-consuming,” said Associate Professor McClements. “Our test has the potential to make a real difference for both mothers and babies.”
News
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
